Abstract
Since 1970, there has been a remarkable improvement in Japan in the outcome of surgery for patients with gastric cancer. Not only the increased rate of detection of early gastric cancer but the standardization of the prophylactic extended lymphadenectomy (ELX) has brought about a remarkable rise in survival rate. In patients with regional lymph node metastasis, we obtained a 5 year survival rate of 39 percent in the ELX group, whereas the rate was only 18 percent in the simple gastrectomy group. The difference was statistically significant (P<0.001). As to adjuvant chemotherapy, the Cooperative Study Group of Surgical Adjuvant Chemotherapy for Gastric Cancer found in data on 1,805 patients followed for 5 years that the protocol, intraoperative bolus intravenous injection of Mitomycin C (MMC) plus oral administration of Futraful (Tegafur) for 3 months, concomitantly applied with ELX, proved to be effective for improving the survival of patients with advanced cancer such as stage III and positive lymph node metastasis with obvious serosal invasion. The 5 year survival rate of Japanese patients with gastric cancer after resective surgery was an overall 56 percent, 48 percent when confined to those with stage III cancer.
Similar content being viewed by others
References
Kodama Y, Sugimachi K, Soejima K, Matsusaka T, Inokuchi K. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg 1981; 5: 241–248.
Kodama, Y, Kano, T, Tamada, R, Kumashiro, R, Okamura, T, Inokuchi, K. Combined effect of prophylactic lymphadenectomy and long term combination chemotherapy for curatively resected carcinoma of the stomach. Jpn J Surg 1982; 12: 244–248.
Japanese Research Society for Gastric Cancer. The General Rules for Gastric Cancer Study in Surgery and Pathology. Jpn J Surg 1981; 11: 127–139.
Honda, T.. The 10 year survival rate of early gastric cancer. Gastroenterological Endoscopy 1977; 19: 613–629 (in Japanese)
Jinnai, D. Evaluation of extended radical operation for gastric cancer, with regard to lymph node metastasis and follow up results. Gann 1968; 3: 225–231.
Inokuchi, K, Hattori, T, Taguchi, T, Abe, O, Ogawa, N. Postoperative adjuvant chemotherapy for gastric carcinoma-analysis of data on 1,805 patients followed 5 years. Cancer 1984; 53: 2393–2397.
Kasai Y, Inokuchi K, Hattori T, Inoue K, Taguchi T, Kondo T, Akiyama H, Abe O, Ito I, Nakajima T, Muto, T, Kikuchi, K, Sugie S, Hayasaka A. Cooperative study group of surgical adjuvant chemotherapy for gastric cancer in Japan-: Randomized study on long-term adjuvant chemotherapy with Futraful and Mitomycin C for gastric cancer—The second study-: Gan to Kagakuryoho 1982; 9: 1449–1660. (in Japanese)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Inokuchi, K. Prolonged survival of gastric cancer patients on a specific adjuvant chemotherapy. The Japanese Journal of Surgery 14, 351–359 (1984). https://doi.org/10.1007/BF02469540
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02469540